REGENERON PHARMACEUTICALS, INC.

A biotech firm inventing, developing, and commercializing medicines for serious diseases.

REGN | US

Overview

Corporate Details

ISIN(s):: US75886F1075
LEI:
Country:: United States of America
Address:: 777 OLD SAW MILL RIVER ROAD, 10591 TARRYTOWN
Website:: https://www.regeneron.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Founded in 1988, the company leverages its scientific and technological capabilities to produce a portfolio of treatments and a pipeline of product candidates. Its research and development efforts span multiple therapeutic areas, including ophthalmology, oncology, cardiovascular and metabolic diseases, and inflammatory conditions. Regeneron focuses on turning cutting-edge science into transformative medicines, with active programs in areas such as genetic medicines (including CRISPR), cancer-fighting immunotherapies, and treatments for obesity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REGENERON PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REGENERON PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for REGENERON PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Cellectis S.A. Developing allogeneic CAR T-cell cancer immunotherapies using TALEN® gene-editing technology.	United States of America	CLLS
Cellid Co., Ltd. Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.	South Korea	299660
Cellromax Science Co., Ltd. Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.	South Korea	471820
CellSeed Inc. Develops cell sheet products, culture equipment, and offers contract manufacturing services.	Japan	7776
CellSource Co.,Ltd. Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.	Japan	4880
Celltrion, Inc. A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.	South Korea	068270
Celon Pharma S.A. Researches, develops, and markets innovative drugs for oncology and neurology.	Poland	CLN
CEL SCI CORP Develops immunotherapies for cancer, autoimmune, and infectious diseases.	United States of America	CVM
Celularity Inc Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.	United States of America	CELU
Centessa Pharmaceuticals plc Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.	United States of America	CNTA